These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19424090)

  • 21. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
    Bonnet S; Michelakis ED; Porter CJ; Andrade-Navarro MA; Thébaud B; Bonnet S; Haromy A; Harry G; Moudgil R; McMurtry MS; Weir EK; Archer SL
    Circulation; 2006 Jun; 113(22):2630-41. PubMed ID: 16735674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia.
    Favret F; Henderson KK; Allen J; Richalet JP; Gonzalez NC
    J Appl Physiol (1985); 2006 Jan; 100(1):20-5. PubMed ID: 16179398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
    Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.
    Caruso P; MacLean MR; Khanin R; McClure J; Soon E; Southgate M; MacDonald RA; Greig JA; Robertson KE; Masson R; Denby L; Dempsie Y; Long L; Morrell NW; Baker AH
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):716-23. PubMed ID: 20110569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
    Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP
    J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of thromboxane A2 on chronic hypoxic pulmonary hypertension in the rat].
    Saito M; Tatsumi K; Kasahara Y; Sugito K; Igari H; Tani T; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):37-44. PubMed ID: 8717289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Dhein S; Giessler C; Heinroth-Hoffmann I; Leineweber K; Seyfarth T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):87-95. PubMed ID: 11819025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
    Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
    Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.
    Kay JM; Suyama KL; Keane PM
    Thorax; 1982 Dec; 37(12):927-30. PubMed ID: 6820578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
    J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary vascular tone is dependent on the central modulation of sympathetic nerve activity following chronic intermittent hypoxia.
    Shirai M; Tsuchimochi H; Nagai H; Gray E; Pearson JT; Sonobe T; Yoshimoto M; Inagaki T; Fujii Y; Umetani K; Kuwahira I; Schwenke DO
    Basic Res Cardiol; 2014; 109(5):432. PubMed ID: 25139633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia.
    Hampl V; Herget J
    Am Rev Respir Dis; 1990 Sep; 142(3):619-24. PubMed ID: 2389914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.
    Eguchi M; Ikeda S; Kusumoto S; Sato D; Koide Y; Kawano H; Maemura K
    Life Sci; 2014 Nov; 118(2):306-12. PubMed ID: 24853385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ATP synthase/coupling factor 6 in hypoxic pulmonary arterial hypertension: An experimental rat model.
    Lı N; Shı Y; Yın J; Sun L; Zhang Q; Bao S; Zhang J; Lı Y; Wang M; Zhang Y; Xue M; Qı L; Lı Y; Yan S; Lı X
    Turk J Med Sci; 2022 Oct; 52(5):1468-1477. PubMed ID: 36422496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary vasoconstrictor responses].
    Onodera S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():15-25. PubMed ID: 1363972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
    Ye L; Jiang Y; Zuo X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.